Annual indirect costs secondary to headache disability in Brazil

Oliveira, Arão Belitardo de; Queiroz, Luiz Paulo; Rocha-Filho, Pedro Augusto Sampaio; Sarmento, Elder Machado; Peres, Mario F. P.

doi:10.1177/0333102419889357

Cited by 18 publications

(19 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…13 A Brazilian study found there was a total toll of R$37.5 billion annually to the workforce due to migraine, R$22.4 billion due to absenteeism, and R$15.1 due to presenteeism. 12 A prospective web-based survey involving 509 full-time U.S. workers with episodic migraines (mean 3 attacks per person) demonstrated that 68% of migraine attacks impacted on work productivity. 40 It is estimated that 28% of these migraines caused absenteeism (with 1169 hours lost in total), and 62% of these migraines caused presenteeism (1470 hours lost or 1% of total lost productivity).…”

Section: Discussionmentioning

confidence: 99%

“…11 In Brazil, researchers have estimated a loss of R$37.5 billion (US$9.6 billion) annually from indirect (productivity) costs and 45.1 million years lived with disability. 12 In Sweden, the productivity burden was estimated to be €10,790 (US$12,083) per person per year, and almost 3 times higher among people with chronic than episodic migraine. 13 However, no study has thus far estimated lost productivity due to migraine in a longitudinal manner; that is, over an extended period of time.…”

Section: Introductionmentioning

confidence: 99%

“…In that year, the estimated productivity cost per person was AU$11,132 (US$7562) 10 for chronic migraine sufferers and AU$2707 (US$1839) for episodic migraine sufferers 11 . In Brazil, researchers have estimated a loss of R$37.5 billion (US$9.6 billion) annually from indirect (productivity) costs and 45.1 million years lived with disability 12 . In Sweden, the productivity burden was estimated to be €10,790 (US$12,083) per person per year, and almost 3 times higher among people with chronic than episodic migraine 13 …”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

The Health and Productivity Burden of Migraines in Australia

Liew

Ademi

et al. 2020

Headache

View full text Add to dashboard Cite

Objective This study aimed to quantify the health and productivity burden of migraines in Australia, measured by quality‐adjusted life years (QALYs), productivity‐adjusted life years (PALYs, a novel measure of productivity), and associated health‐care and broader economic costs. Methods A Markov state‐transition model was constructed to simulate follow‐up of Australians aged 20‐64 years over the next 10 years. The model was first run using current prevalence estimates of migraine. It was then rerun assuming that people with migraine hypothetically did not have the condition. Differences in outcomes between the 2 model simulations represented the health and productivity burden attributable to migraine. All data inputs were obtained from published sources. Gross domestic product (GDP) per equivalent full‐time worker in Australia was used to reflect the cost of each PALY (AU$177,092). Future costs and outcomes were discounted by 5% annually. Results Currently, 1,274,319 million (8.5%) Australians aged 20‐64 years have migraine. Over the next 10 years, migraine was predicted to lead to a loss of 2,577,783 (95% confidence interval [CI] 2,054,980 to 3,000,784) QALYs among this cohort (2.02 per person and 2.43% of total QALYs), and AU$1.67 (95% CI $1.16 to $2.37) billion in health‐care costs (AU$1313 per person, 95% CI $914 to $1862). There would also be 384,740 (95% CI 299,102 to 479,803) PALYs lost (0.30 per person and 0.53% of total PALYs), resulting in AU$68.13 (95% CI $44.42 to $98.25) billion of lost GDP (AU$53,467 per person, 95% CI $34,855 to $77,102). Conclusion Migraines impose a substantial health and economic burden on Australians of working age. Funding interventions that reduce the prevalence of migraines and/or its effects are likely to provide sound return on investment.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The Health and Productivity Burden of Migraines in Australia

Liew

Ademi

et al. 2020

Headache

View full text Add to dashboard Cite

show abstract

“…Migraine has been found to cause a large economic impact owing to the direct and indirect expenses associated with it [6][7][8][9][10][11][12][13][14][15] . While direct costs include resource use and the expenditures incurred for medically managing the disease, indirect costs include losses (e.g.…”

Section: Introductionmentioning

confidence: 99%

Healthcare resource use and indirect costs associated with migraine in Italy: results from theMy Migraine Voicesurvey

Martelletti

Schwedt

et al. 2021

Journal of Medical Economics

View full text Add to dashboard Cite

Aims: To evaluate the healthcare resource use (HRU) and cost of lost productivity due to migraine among Italians with !4 monthly migraine days (MMDs), with a focus on those with !2 prior preventive treatment failures (TFs). Materials and methods: Data from Italian participants from the My Migraine Voice survey were used to assess migraine-related HRU and migraine's impact on work productivity and daily activities using the Work Productivity and Activity Impairment questionnaire. The mean, annualized cost of lost productivity was estimated using the Human Capital Approach and extrapolated to employed Italian population with !4 MMDs to calculate the overall migraine-related indirect cost burden in Italy. Results: Data of 420 participants, enrolled between September 2017 and February 2018, were analyzed (mean age: 38.5 years, 81.2% women, 37.8% with !2 TF). During a 6-month period, 57.6% of participants visited general practitioners (mean visits: 4.5), 31.9% neurologists (mean visits: 2.6), and 26.4% headache specialists (mean visits: 2.8). Overall, 32.0% of participants had !1 emergency room visit (mean visits: 2.8) and 15.0% had !1 hospitalization (mean visits: 2.9) because of migraine in the past 12 months. Participants who were employed (N ¼ 215) reported 15.5% absenteeism, 45.3% presenteeism, 53.8% overall work impairment, and 52.6% activity impairment. The mean annualized indirect cost was estimated to be e14,368. The annual indirect cost burden was estimated to be e7.6 billion for the employed Italian population with !4 MMDs. The impact of migraine was particularly high among the !2 TF subgroups on all parameters. The indirect cost was estimated to be e15,881 (e5,007 attributed to absenteeism). Conclusion: Migraine-related HRU and indirect costs are high among individuals with !4 MMDs (particularly those with !2 TF). There is a need for more effective treatments and better management of migraines to reduce the functional and economic burden among this difficult-to-treat population.

show abstract

“…Few studies have explored emergency care due to cephalalgia in Brazil 4 . The aim of the present study was to assess the frequency of emergency care due to headache, included migraine, along with the demographic characteristics and treatment offered.…”

Section: Introductionmentioning

confidence: 99%

Impact of headache on a supplemental healthcare emergency unit and on use of opioids

Silva

Kiy

Alves

et al. 2021

Arq. Neuro-Psiquiatr.

View full text Add to dashboard Cite

Background: Headache is one of the most common causes of emergency care and migraines are the most common primary headache in this regard. Objective: The aim of this research study was to assess the incidence of medical consultations due to headache, along with demographic characteristics and treatments pertaining to cephalalgia that were offered to patients cared for in supplemental healthcare emergency rooms. Methods: In 2017, a total of 11,105 consultations took place, and 4,865 (43.8%) of them were complaints relating to headache. 407 records of patients with headache were randomly selected and assessed. Demographic, clinical and therapeutic data were collected using a structured form. Results: The cause of headache was diagnosed as migraine in 60.0% of the patient records. Patients were mostly female (75.2%), with an average age of 33.9 ± 13.7 years. Patient management consisted of administering dipyrone in 62.4% of cases, antiemetics in 66.9%, corticosteroids in 58.9%, opioids in 24.3% and NSAIDs in 13.5%. Use of opioids was associated with a diagnosis of migraine (OR 2.4; CI 1.4-3.9; p = 0.001). Patients who received opioids were kept under observation for longer periods of time (OR 3.4; CI 2.1-5.4; p < 0.001) and exhibited a higher rate of use of antiemetics (OR 11.0; CI 4.7-25.9; p < 0.001), compared with patients who did not receive opioids. Conclusion: Dipyrone and antiemetics were administered to most of the patients. Opioids were used for a significant proportion of these individuals, despite the diagnosis of migraine, a condition for which their use is discouraged.

show abstract

Annual indirect costs secondary to headache disability in Brazil

Cited by 18 publications

References 29 publications

The Health and Productivity Burden of Migraines in Australia

The Health and Productivity Burden of Migraines in Australia

Healthcare resource use and indirect costs associated with migraine in Italy: results from theMy Migraine Voicesurvey

Impact of headache on a supplemental healthcare emergency unit and on use of opioids

Contact Info

Product

Resources

About